Try our Advanced Search for more refined results

February 17, 2006

In Re: Celexa and Lexapro Products Liability Litigation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 09, 2013

    Forest Labs Skirts Sanctions In Lexapro, Celexa Suicide MDL

    A Missouri federal judge on Tuesday refused to sanction Forest Laboratories Inc. over CEO Howard Solomon's deposition testimony in a multidistrict litigation over the suicide risks of the antidepressant drugs Lexapro and Celexa, ruling that Soloman did not behave inappropriately when answering questions.

9 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!